Health-Care Funds Advance
As Biotechs Stage Recovery
By 
 Updated Jan. 28, 2000 11:59 p.m. ET 
 
Health-care mutual funds may be on the mend.
After turning in a relatively weak performance last year, funds devoted to pharmaceuticals, biotechnology and other medical stocks are one of the few fund categories sporting a gain so far this year. The average health-care fund is up about 10.59% through this week, according to Lipper Inc. That sure beats the average U.S. stock fund, which is down 1.08%.
Health-care funds were laid...
